Raj's dashboard, updated Sunday, shows PQ.2 as standout child of Nimbus NB.1.8.1 / PQ; Stratus XFG overtaken by child XFG.2; and LP.8.1 long ago overshadowed by LP.8.1.1/ NY.

GISAID data for the most recent fortnight is dominated by submissions from New York (with all of 58 sequences), followed by Florida (with 17).

#CDC's most recent Friday dataset, updated Tuesday June 24, showed Nimbus taking plurality, with Stratus XFG family also gaining share.

FDA vaccine target LP.8.1, dominant since March, plateaued in April. June saw Nimbus NB.1.8.1 / PQ, scion of "razor-blade throat" XDV, push LP.8.1 out of majority.

❖ #ThisIsOurPolio #variants #CovidIsNotOver #dataviz #datavis

Raj's dashboard, updated this morning, shows PQ.2 as standout child of Nimbus NB.1.8.1 / PQ; Stratus XFG overtaken by child XFG.2; and LP.8.1 long ago overshadowed by LP.8.1.1/ NY.

FDA vaccine target LP.8.1, dominant since March, plateaued in April. June saw Nimbus NB.1.8.1 / PQ, scion of "razor-blade throat" XDV, push LP.8.1 out of majority.

#CDC's most recent Friday dataset, updated Tuesday June 24, showed Nimbus taking plurality, with Stratus XFG family also gaining share.

Despite notice of moving to "longer reporting periods", for reason of "low number of sequences being reported" (see dot-hatching in below chart reflecting"less reliable" data), now three-weeks old dataset was still for periods two-weeks each.

❖ #ThisIsOurPolio #variants #CovidIsNotOver #dataviz #datavis

Raj's dashboard, last updated July 3, showed PQ.2 as standout child of Nimbus NB.1.8.1 / PQ; Stratus XFG in competition with kids XFG.2 and XFG.3; and LP.8.1 long ago overshadowed by LP.8.1.1/ NY.

FDA vaccine target LP.8.1, dominant since March, plateaued in April. June saw Nimbus NB.1.8.1 / PQ, scion of "razor-blade throat" XDV, push LP.8.1 out of majority.

#CDC's most recent Friday dataset, updated Tuesday June 24, showed Nimbus taking plurality, with Stratus XFG family also gaining share.

Despite notice of moving to "longer reporting periods", for reason of "low number of sequences being reported" (see dot-hatching in below chart reflecting"less reliable" data), now three-weeks old dataset was still for periods two-weeks each.

❖ #ThisIsOurPolio #variants #CovidIsNotOver #dataviz #datavis

Raj's dashboard, updated this morning, shows PQ.2 as standout child of Nimbus NB.1.8.1 / PQ; Stratus XFG in competition with kids XFG.2 and XFG.3; and LP.8.1 long ago overshadowed by LP.8.1.1/ NY.

FDA vaccine target LP.8.1, dominant since March, plateaued in April. June saw Nimbus NB.1.8.1 / PQ, scion of "razor-blade throat" XDV, push LP.8.1 out of majority.

#CDC's last Friday dataset, updated Tuesday last week, showed Nimbus taking plurality, with Stratus XFG family also gaining share. Despite notice of moving to "longer reporting periods", for reason of "low number of sequences being reported" (see dot-hatching in below chart reflecting"less reliable" data), current dataset was still for periods two-weeks each.

❖ #ThisIsOurPolio #variants #CovidIsNotOver #dataviz #datavis

FDA vaccine target LP.8.1, dominant since March, plateaued in April. June saw Nimbus NB.1.8.1 / PQ, scion of "razor-blade throat" XDV, push LP.8.1 out of majority.

#CDC's last Friday dataset, updated Tuesday this week, shows Nimbus taking plurality, with Stratus XFG family also gaining share. Despite notice of moving to "longer reporting periods", for reason of "low number of sequences being reported" (see dot-hatching in below chart reflecting"less reliable" data), current dataset was still for periods two-weeks each.

Raj's dashboard, updated Sunday, shows PQ.2 as standout child of Nimbus NB.1.8.1 / PQ; Stratus XFG in competition with kids XFG.2 and XFG.3; and LP.8.1 long ago overshadowed by LP.8.1.1/ NY.

❖ #ThisIsOurPolio #variants #CovidIsNotOver #dataviz #datavis

FDA vaccine target LP.8.1, dominant since March, plateaued in April. June saw Nimbus NB.1.8.1 / PQ, scion of "razor-blade throat" XDV, push LP.8.1 out of majority.

Due to "low numbers of sequences being reported" (as evidenced by "less reliable" dot hatching on below chart), #CDC did not publish data this week, having advised only of "moving to longer reporting periods":

https://hcommons.social/@beadsland/114662142357659963

Raj's dashboard, updated this morning, shows PQ.2 as standout child of Nimbus NB.1.8.1 / PQ; Stratus XFG in competition with kids XFG.2 and XFG.3; and LP.8.1 long ago overshadowed by LP.8.1.1/ NY.

❖ #ThisIsOurPolio #variants #CovidIsNotOver #dataviz #datavis

FDA vaccine target LP.8.1, dominant since March, plateaued in April. June sees Nimbus NB.1.8.1, scion of "razor-blade throat" XDV, push LP.8.1 out of majority.

#CDC added NB.1.8.1 only in latest, late-published public dataset. Notice of "software error" that heralded data delay… has been removed. Hatching for "less reliable" data reflects "low numbers of sequences being reported".

Raj's dashboard, updated this morning, shows Nimbus diversifying in May. Also, XFJ significant, even if CDC hasn't broken out.

❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #dataviz #datavis

Two weeks ago, Mike Honey noted that there are three recombinants that have arrived on Doppelgänger spike proteins, namely XFJ, XFM, and XFP:

https://aus.social/@mike_honey_/114611686572899925

Last week, Xu Zhu (HT D. Focosi) identified a superset of recombinants that have all arrived at a pairing of LF.7's NTD with RBD from elsewhere, namely: XFC, XFG, XFH, XFJ, XFM, XFN and XFP:

https://x.com/dfocosi/status/1931351676880879856

Above variants chart #AnnoPlot script is now updated to favor grouping by such emerging clusters preferentially over grouping by legacy ancestors.

As a reminder, recombinants happen when more than one virus strain is actively replicating in the same organism.

Here, that means two simultaneous infections, from different sources, finding a home in the same person.

When #PublicHealth is a priority, this should be a rare occurrence.

There are seven unique recombinants identified in this new cluster, alone.

❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #dataviz #datavis

FDA vaccine target LP.8.1, dominant since March, plateaued in April. June sees Nimbus NB.1.8.1, scion of "razor-blade throat" XDV, push LP.8.1 out of majority.

#CDC adds NB.1.8.1 only in latest, late-published public dataset. "Software error" that heralded data delay remains unresolved. Hatching for "less reliable" data reflects "low numbers of sequences being reported".

Raj's dashboard, updated Sunday, shows Nimbus diversifying in May.

❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #dataviz #datavis

Since March, LP.8.1 has been dominant. FDA designated same as vaccine target, on very week its share had plateaued.

Data collection continued to be low priority nationally—as exactly zero regions had enough data for CDC to plot.

#CDC released no new data this week, due to "software issue". This after data was delayed two weeks ago by holiday weekend.

The "razor-blade throat" XDV scion, Nimbus NB.1.8.1, near doubled its share in GISAID from two weeks prior, per Raj's dashboard, updated today.

❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #dataviz #datavis

Since March, LP.8.1 has been dominant. FDA designates same as vaccine target, on very week its share has plateaued.

Data collection continues to be low priority nationally—as exactly zero regions have enough data for CDC to plot.

No new variants broken out by #CDC, although the "razor blade throat" variant, NB.1.8.1, remains significant in GISAID.

Raj's dashboard was last updated yesterday.

❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #dataviz #datavis

Updated #CDC estimates show we'd pretty much been in a JN.1.11 soup since Dec, until late March, when LP.8.1 took majority.

Data collection continues to be low priority nationally—as exactly zero regions have enough data for CDC to plot.

CDC breaks out recombinant XFC from FLiRT parent LF.7 . (Our dataviz now identifies parentage for each recombinant.) Raj's dashboard was last updated today.

❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #dataviz #datavis

Updated #CDC estimates show we'd pretty much been in a JN.1.11 soup since Dec, until late March, when LP.8.1 took majority.

Data collection continues to be a low priority nationally, as exactly zero regions have enough data for CDC to plot.

Two children of LF.7.7, dot1 and dot2, broken out by CDC, together with PA.1, a grandchild of MC.10.

Raj's dashboard was last updated a week ago today.

❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #dataviz #datavis

Updated #CDC estimates show we've pretty much been in a JN.1.11 soup since Dec, until late March, when LP.8.1 took majority.

Data collection continues to be a low priority nationally, as exactly zero regions have enough data for CDC to plot.

No new variants broken out, yet CDC seems to have resources to tailor their color key: https://hcommons.social/@beadsland/114163320179234281

Raj's dashboard was updated on today.

❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #dataviz #datavis

Updated #CDC estimates show we've pretty much been in a JN.1.11 soup since Dec, until late March, when LP.8.1 took majority.

Data collection continues to be a low priority nationally, as only one region (NY/NJ) has enough data for CDC to plot.

No new variants broken out, yet CDC seems to have resources to tailor their color key: https://hcommons.social/@beadsland/114163320179234281

Raj's dashboard was updated on Sunday.

❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #dataviz #datavis